Intestinal microbiota in pediatric surgical cases administered bifidobacterium breve: A randomized controlled trial

Journal of Pediatric Gastroenterology and Nutrition

Volumn 63, Issue 1, 2016, Pages 46-50

  Okazaki, Tadaharu ^a   Asahara, Takashi ^b   Yamataka, Atsuyuki ^a   Ogasawara, Yuki ^a   Lane, Geoffrey J ^a   Nomoto, Koji ^b   Nagata, Satoru ^a,c   Yamashiro, Yuichiro ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

children; intestinal microbiota; probiotics; surgery

Indexed keywords

ACETIC ACID; ANTIBIOTIC AGENT; PLACEBO; PROBIOTIC AGENT;

ABSENCE OF SIDE EFFECTS; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; BACTERIUM DETECTION; BIFIDOBACTERIUM; BIFIDOBACTERIUM BREVE; CHILD; CHOLANGITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; ENTEROBACTERIACEAE; FECES ANALYSIS; FECES MICROFLORA; FEMALE; HUMAN; INCIDENCE; INFECTIOUS COMPLICATION; INTESTINE FLORA; MALE; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; PEPTOCLOSTRIDIUM DIFFICILE; PERIOPERATIVE PERIOD; PILOT STUDY; PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PSEUDOMONAS; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SURGICAL INFECTION; TREATMENT OUTCOME; ADOLESCENT; FECES; INTESTINE; MICROBIOLOGY; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; SURGERY;

ADOLESCENT; BIFIDOBACTERIUM; CHILD; CHILD, PRESCHOOL; FECES; FEMALE; HUMANS; INTESTINES; MALE; PERIOPERATIVE CARE; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROBIOTICS; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME;

EID: 84957828223     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000001140     Document Type: Article

References (16)

1. Mizuno T, Yokoyama Y, Nishio H, et al. Intraoperative bacterial translocation detected by bacterium-specific ribosomal RNA-targeted reverse-transcriptase polymerase chain reaction for the mesenteric lymph node strongly predicts postoperative infectious complications after major hepatectomy for biliary malignancies. Ann Surg 2010; 252: 1013-9.
2. Reid G. Food and Agricultural Organization of the United Nation and the WHO. The importance of guidelines in the development and application of probiotics. Curr Pharm 2005; 11: 11-6.
3. Ashraf R, Shah NP. Immune system stimulation by probiotic microorganisms. Crit Rev Food Sci Nutr 2014; 54: 938-56.
4. Sugawara G, Nagino M, Nishio H, et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg 2006; 244: 706-14.
5. Yokoyama Y, Nishigaki E, Abe T, et al. Randomized clinical trial of the effect of perioperative synbiotics versus no synbiotics on bacterial translocation after oesophagectomy. Br J Surg 2014; 101: 189-99.
6. Tojo M, Oikawa T, Morikawa Y, et al. The effects of Bifidobacterium breve administration on Campylobacter enteritis. Acta Paediatr Jpn 1987; 29: 160-7.
7. Umenai T, Shime N, Asahara T, et al. A pilot study of Bifidobacterium breve in neonates undergoing surgery for congenital heart disease. J Intensive Care 2014; 2: 36.
8. Sato J, Kanazawa A, Ikeda F, et al. Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes. Diabetes Care 2014; 23: 2343-50.
9. Matsuda K, Tsuji H, Asahara T, et al. Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environ Microbiol 2007; 73: 32-9.
10. Matsuda K, Tsuji H, Asahara T, et al. Establishment of an analytical system for the human fecal microbiota, based on reverse transcriptionquantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol 2009; 75: 1961-9.
11. Matsuda K, Tsuji H, Asahara T, et al. Sensitive quantification of Clostridium difficile cells by reverse transcription-quantitative PCR targeting rRNA molecules. Appl Environ Microbiol 2012; 78: 5111-8.
12. Fujimoto J, Tanigawa K, Kudo Y, et al. Identification and quantification of viable Bifidobacterium breve strain Yakult in human faeces by using strain-specific primers and propidium monoazide. J Appl Microbiol 2010; 110: 209-17.
13. Wada M, Nagata S, Saito M, et al. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support Care Cancer 2010; 18: 751-9.
14. Kanamori Y, Iwanaka T, Sugiyama M, et al. Early use of probiotics is important therapy in infants with severe congenital anomaly. Pediatr Int 2010; 52: 362-7.
15. Kanazawa H, Nagino M, Kamiya S, et al. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 2005; 390: 104-13.
16. Asahara T, Shimizu K, Nomoto K, et al. Probiotic Bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157: H7. Infect Immun 2004; 72: 2240-7.